Android (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Android drug offered from Valeant Pharmaceuticals North America LLC. This Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: MethylTESTOSTERone
SUBSTANCE NAME: METHYLTESTOSTERONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1973-12-03
END MARKETING DATE: 2018-04-30


Android HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAndroid from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 1973-12-03
END MARKETING DATE: 2018-04-30
PRODUCT ID: 0187-0902_66762a5d-622d-4cb7-a217-68710c0c6f55
PRODUCT NDC: 0187-0902
APPLICATION NUMBER: ANDA083976

Other METHYLTESTOSTERONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Impax GenericsMETHITEST
Valeant Pharmaceuticals North America LLCTestred